GrayMatters Health


GrayMatters Health is transforming mental healthcare by providing evidence-based technology that enhances standard-of-care therapies. Their flagship product, Prism for PTSD, is the first FDA-cleared self-neuromodulation device designed to help patients manage PTSD symptoms through innovative brain activity regulation techniques.

Gray Matters Health Logo

GrayMatters Health

Derech HaAtsma’ut 82, Haifa Israel 3303403


What We Do

Prism for PTSD is an FDA-cleared self-neuromodulation device that helps patients learn to regulate brain activity associated with PTSD symptoms. It uses a computer simulation and EEG headset to create a non-trauma-based experience for patients, allowing them to control their PTSD symptoms effectively.



Key People

Inventor, SAB Chairperson, Chief Medical Scientist

LinkedIn

CEO, President, Co-founder

LinkedIn

Executive Chairman BOD, Co-founder

LinkedIn

VP R&D, Co-founder

LinkedIn

VP Clinical, Regulatory & Quality Affairs

LinkedIn

Chief Medical Officer

LinkedIn

News & Updates

GrayMatters Health continues to broaden patient access of Prism for PTSD across the US.

GrayMatters Health expands access to its FDA-cleared Prism for PTSD treatment for veterans and civilians.

GrayMatters Health wins the Edison Gold Award for its innovative PTSD treatment.

A study highlights the efficacy of Prism for PTSD in alleviating chronic PTSD symptoms.

GrayMatters Health's Prism for PTSD received recognition as a groundbreaking category-changer to improve lives for the better.

GrayMatters Health was recognized as a Most Innovative Company by Fast Company.